HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Estimated background doses of [67Ga]-DTPA-USPIO in normal Balb/c mice as a potential therapeutic agent for liver and spleen cancers.

AbstractINTRODUCTION:
The aim of this study was to evaluate the biodistribution of dextran-coated iron oxide nanoparticles labeled with gallium-67 (Ga) in various organs by intravenous injection in Balb/c mice.
METHODS:
Ultrasmall superparamagnetic iron oxide (USPIO) was successively labeled with Ga-chloride after chelation with freshly prepared cyclic DTPA-dianhydride. The labeling efficiency of USPIOs labeled with Ga is above 98%. Sixty-five mice were killed at 13 different time points. The percentage of injected dose per gram of each organ was measured by direct counting for 19 harvested organs of the mice. The medical internal radiation dose formula was applied to extrapolate data from mouse to human and to predict the absorbed radiation dose for various organs in the human body.
RESULTS:
The biodistribution of Ga-USPIO in Balb/c mice showed that 75% of the injected dose accumulated in the spleen and liver 15 min after injection. These nanoparticles remained in the liver for more than 7 days after injection, whereas their clearance was very fast from other organs. Extrapolating these data to the intravenous injection of Ga-USPIO in humans gave an estimated absorbed dose of 36.38 mSv/MBq for the total body, and the highest effective absorbed dose was seen in the liver (32.9 mSv/MBq).
CONCLUSION:
High uptakes of USPIO nanoparticles in the liver and spleen and their fast clearance from other tissues suggest that these nanoparticles labeled with a β-emitter radioisotope could be suitable as treatment agents for spleen and liver malignancies only if the organ tolerance dose is not exceeded.
AuthorsSaeed Shanehsazzadeh, Mohammad A Oghabian, Afsaneh Lahooti, Mohammad Abdollahi, Seyed Abolghasem Haeri, Massoud Amanlou, Fariba J Daha, Barry J Allen
JournalNuclear medicine communications (Nucl Med Commun) Vol. 34 Issue 9 Pg. 915-25 (Sep 2013) ISSN: 1473-5628 [Electronic] England
PMID23892445 (Publication Type: Journal Article)
Chemical References
  • Ferric Compounds
  • Gallium Radioisotopes
  • ferric oxide
  • Gadolinium DTPA
Topics
  • Animals
  • Background Radiation
  • Female
  • Ferric Compounds (chemistry)
  • Gadolinium DTPA (administration & dosage, chemistry, pharmacokinetics, therapeutic use)
  • Gallium Radioisotopes (therapeutic use)
  • Humans
  • Injections, Intravenous
  • Liver Neoplasms (radiotherapy)
  • Magnets (chemistry)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Radiation Dosage
  • Radiotherapy Dosage
  • Splenic Neoplasms (radiotherapy)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: